NCT04335890 2026-03-04
IKKb-matured, RNA-loaded Dendritic Cells for Metastasised Uveal Melanoma
Hasumi International Research Foundation
Phase 1 Completed
Clinical Trials
13 trialsNCT07113379 2025-08-08
REVIVE
Clinica Universidad de Navarra, Universidad de Navarra
Not yet recruiting
NCT05938192 2025-05-09
Multimodality Treatments of HPV-related Lesions of the Female Genital Tract
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Recruiting
NCT04814446 2025-01-23
VAC-WARTS
Assistance Publique - Hôpitaux de Paris
Phase 3 Recruiting
NCT05356312 2024-03-01
Glioblastoma and Individualized Therapies
Zentrum fur Humangenetik Tuebingen
Available
NCT03619252 2022-08-31
Pneumococcal Vaccination of Multiple Myeloma Patients on Novel Agents
Minsk Scientific-Practical Center for Surgery, Transplantation and Hematology
Phase 4 Completed
NCT03373656 2022-07-26
Vaccination for Children of H&O and Their Parents
Children's Cancer Group, China
Phase NA Unknown
NCT01390064 2019-08-20
Vaccination of High Risk Breast Cancer Patients
University of Arkansas
Phase 1 Completed
NCT01342224 2018-04-12
Immunochemoradiotherapy in Patients With Pancreatic Cancer
Providence Health & Services
Phase 1 Completed
NCT03296397 2018-02-27
CONDYVAC
Assistance Publique - Hôpitaux de Paris
Phase 3 Unknown
NCT01042366 2017-08-16
Dendritic Cells (DC) Vaccine for Metastatic Melanoma
University of Pittsburgh
Phase 2 Terminated
NCT01216436 2015-05-25
Local Modulation of Immune Receptors to Enhance the Response to Dendritic Cell Vaccination in Metastatic Melanoma
Duke University
Phase 1 Terminated
NCT01267578 2010-12-28
Peptide Vaccination in Treating Patients With Esophageal Cancer (STF-II)
University of Yamanashi
Phase 2 Unknown